Pierre Dillard
Oslo, Norway
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 13 publications
Efficient chimeric antigen receptor targeting of a central epitope of CD22.
Journal: The Journal of biological chemistry
Published: November 17, 2022
Targeting KRAS mutations with HLA class II-restricted TCRs for the treatment of solid tumors.
Journal: Oncoimmunology
Published: July 08, 2021
Combinatorial CAR design improves target restriction.
Journal: The Journal of biological chemistry
Published: October 09, 2020
Targeting Telomerase with an HLA Class II-Restricted TCR for Cancer Immunotherapy.
Journal: Molecular therapy : the journal of the American Society of Gene Therapy
Published: June 16, 2020
Correction to: Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: November 29, 2019
Colorectal cysts as a validating tool for CAR therapy.
Journal: BMC biotechnology
Published: November 16, 2019
A Spheroid Killing Assay by CAR T Cells.
Journal: Journal of visualized experiments : JoVE
Published: January 01, 2019
Preclinical development of CD37CAR T-cell therapy for treatment of B-cell lymphoma.
Journal: Blood advances
Published: December 10, 2018
Preclinical assessment of transiently TCR redirected T cells for solid tumour immunotherapy.
Journal: Cancer immunology, immunotherapy : CII
Published: December 02, 2018
NK cells specifically TCR-dressed to kill cancer cells.
Journal: EBioMedicine
Published: November 08, 2018
Antigen-delivery through invariant chain (CD74) boosts CD8 and CD4 T cell immunity.
Journal: Oncoimmunology
Published: July 28, 2018
Simultaneous defeat of MCF7 and MDA-MB-231 resistances by a hypericin PDT-tamoxifen hybrid therapy.
Journal: NPJ breast cancer
Published: March 18, 2018
Last Updated: 09/26/2026